Autopsy report · NCT00344448

Pilot Study of Raptiva to Treat Sjogren's Syndrome

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Increased risk of PML associated with raptiva in other studies”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 2 years 7 months before it stopped.
10 participants enrolled.
Results were posted on the registry 6 years 11 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Sponsor type: US National Institutes of Health
Conditions: Sjogren's Syndrome
Interventions: Raptiva
Participants: 10
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.